VitaDAO Founds Biotech Firm to Advance Longevity Research, Develop Treatments for Cancer and Age-related Diseases
VitaDAO, a decentralized autonomous organization (DAO), has launched Matrix Biosciences, a biotech company focused on advancing longevity research. Matrix Biosciences, majority-owned by VitaDAO, will operate as a centralized entity and work on developing treatments for cancer and age-related diseases using research on the naked mole-rat. The company aims to demonstrate the compatibility of blockchain technology with the biotech industry and is actively collaborating with regulators to ensure compliance.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
VitaDAO Founds Biotech Firm to Advance Longevity Research, Develop Treatments for Cancer and Age-related Diseases
VitaDAO, a decentralized autonomous organization (DAO), has launched Matrix Biosciences, a biotech company focused on advancing longevity research. Matrix Biosciences, majority-owned by VitaDAO, will operate as a centralized entity and work on developing treatments for cancer and age-related diseases using research on the naked mole-rat. The company aims to demonstrate the compatibility of blockchain technology with the biotech industry and is actively collaborating with regulators to ensure compliance.